Annual SG&A
$0.00$1.46B-100.00%
Summary
- Current Value
- As of today, VRTX annual SG&A is $0.00, down -100.00% on
- Historical Performance
- VRTX annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
- All-Time High Comparison
- VRTX annual SG&A is currently -100.00% below its historical high of $1.46B set on
- Sector Comparison
- VRTX annual SG&A is higher than 72.89% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $56.21B | +3479.4% | +5422.3% | +7077.7% | +10000.0% | |
| Price | $528.19 | +35.5% | +53.2% | +171.2% | +1066.2% | |
| Annual Operating Expenses | $5.68B | +11.6% | +58.4% | +118.6% | +615.0% | |
| Annual Operating Profit | $4.69B | +7.5% | +14.9% | +63.1% | +774.9% | |
| Annual D&A | $209.80M | +1.3% | +41.5% | +91.6% | +588.8% | |
| Annual Revenue | $12.07B | +9.9% | +38.0% | +94.5% | +8322.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.46B | -100.0% | |
| 5Y | $1.46B | -100.0% | |
| All | $1.46B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
- What is the current annual SG&A of VRTX?
- As of today, VRTX annual SG&A is $0.00
- What is 1-year change in VRTX annual SG&A?
- VRTX annual SG&A is down -100.00% year-over-year
- What is 3-year change in VRTX annual SG&A?
- VRTX annual SG&A is down -100.00% over the past 3 years
- How far is VRTX annual SG&A from its all-time high?
- VRTX annual SG&A is currently -100.00% below its historical high of $1.46B set on December 31, 2024
- How does VRTX annual SG&A rank versus sector peers?
- VRTX annual SG&A is higher than 72.89% of companies in Healthcare sector
- When is VRTX next annual earnings release?
- As of today, the next annual earnings release for VRTX has not been scheduled
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Quarterly SG&A
$0.00$493.70M-100.00%
Summary
- Current Value
- As of today, VRTX quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- VRTX quarterly SG&A is down -100.00% year-over-year, down -100.00% over the past 3 years
- All-Time High Comparison
- VRTX quarterly SG&A is currently -100.00% below its historical high of $493.70M set on
- Sector Comparison
- VRTX quarterly SG&A is higher than 61.14% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $56.21B | +2937.8% | +3479.4% | +5422.3% | +7077.7% | |
| Price | $528.19 | +21.0% | +35.5% | +53.2% | +171.2% | |
| Quarterly Operating Expenses | $1.58B | +8.3% | +12.3% | +36.0% | -1.6% | |
| Quarterly Operating Profit | $1.27B | +9.0% | +7.9% | +24.7% | +6862.4% | |
| Quarterly D&A | $56.50M | +1.1% | +9.3% | +36.5% | +80.9% | |
| Quarterly Revenue | $3.34B | +11.0% | +12.0% | +34.6% | +84.7% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $493.70M | -100.0% | |
| 3Y | $493.70M | -100.0% | |
| 5Y | $493.70M | -100.0% | |
| All | $493.70M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
- What is the current quarterly SG&A of VRTX?
- As of today, VRTX quarterly SG&A is $0.00
- What is VRTX quarterly SG&A most recent change?
- VRTX quarterly SG&A was down -100.00% on June 30, 2026
- What is 1-year change in VRTX quarterly SG&A?
- VRTX quarterly SG&A is down -100.00% year-over-year
- How far is VRTX quarterly SG&A from its all-time high?
- VRTX quarterly SG&A is currently -100.00% below its historical high of $493.70M set on March 31, 2026
- How does VRTX quarterly SG&A rank versus sector peers?
- VRTX quarterly SG&A is higher than 61.14% of companies in Healthcare sector
- When is VRTX next earnings release?
- The next earnings release for VRTX is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
TTM SG&A
$56.21B$4.41B+8.50%
Summary
- Current Value
- As of today, VRTX TTM SG&A is $56.21B, up +8.50% on
- Historical Performance
- VRTX TTM SG&A is up +3479.44% year-over-year, up +5422.30% over the past 3 years
- All-Time High Comparison
- VRTX TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- VRTX TTM SG&A is +103.76% above its 3-year low of $27.59B reached on an earlier date
- Sector Comparison
- VRTX TTM SG&A is higher than 97.77% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $56.21B | +2937.8% | +3479.4% | +5422.3% | +7077.7% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $528.19 | +21.0% | +35.5% | +53.2% | +171.2% | |
| TTM Operating Profit | $5.01B | +1.9% | +14.7% | +30.5% | +115.9% | |
| TTM D&A | $222.10M | +2.2% | +11.2% | +43.0% | +91.3% | |
| TTM Revenue | $12.70B | +2.9% | +11.4% | +35.7% | +88.5% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $56.21B | N/A | at high |
| 3Y | $56.21B | N/A | at high |
| 5Y | $56.21B | N/A | at high |
| All | $56.21B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $39.84B | N/A | +41.1% |
| 3Y | $27.59B | N/A | +103.8% |
| 5Y | $4.20B | N/A | +1237.2% |
| All | -$21.45B | N/A | +362.0% |
TTM SG&A History
FAQ
- What is the current TTM SG&A of VRTX?
- As of today, VRTX TTM SG&A is $56.21B
- What is VRTX TTM SG&A most recent change?
- VRTX TTM SG&A was up +8.50% on June 30, 2026
- What is 1-year change in VRTX TTM SG&A?
- VRTX TTM SG&A is up +3479.44% year-over-year
- How far is VRTX TTM SG&A from its all-time high?
- VRTX TTM SG&A is currently at its all-time high
- How does VRTX TTM SG&A rank versus sector peers?
- VRTX TTM SG&A is higher than 97.77% of companies in Healthcare sector
- When is VRTX next earnings release?
- The next earnings release for VRTX is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- VRTX Official Website www.vrtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
- VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
- VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx
